We Develop Innovative Healthcare Solutions Through Cannabis & Mushroom Based Sciences
About Psilosybin & Cannabinoids
Psilocybin – The Active Compound found in various mushrooms. FDA granted “breakthrough therapy” status to psilocybin in 2020. Acknowledgement that Major Depressive Disorder (MDD) represents an unmet medical need and suggests that psilocybin may offer a substantial clinical improvement over existing therapies.
Cannabinoids – The active compounds found in Cannabis. Cannabinoids are commonly used to treat seizure disorder, anxiety, pneumonia, dystonia, Parkinson disease, Crohn disease, and many other conditions.
Drug Target Discovery
Pre-Clinical Trials
Clinical Trials
FDA Approval
The potential for medicinal psychedelics &
cannabinoids have never been this big.
Estimated $100B USD global total addressable market for psychedelics.
“The global medical cannabis market size is projected to reach $97.35B USD by the end of 2026.”
Annual substance abuse treatment sales.
Annual anxiety, depression & ADHD drug sales.